From Bottleneck To Breakthrough: Reimagining The mRNA Therapeutics Supply Chain
Biotechs that develop mRNA therapeutics face several key supply chain challenges that can impact their ability to develop and manufacture products efficiently. One of the primary issues is the limited availability of GMP-grade raw materials and the lack of standardization across the industry for mRNA manufacturing processes. There are cold chain requirements for storage and distribution, and there is a need for specialized equipment. Joseph Barberio, VP Technical Operations at Strand Therapeutics and Christian Moreno, Director of Supply Chain Management at Nutcracker Therapeutics share their insight on what's needed to overcome the top challenges associated with mRNA therapeutics' intricate supply chain.
Available on-demand thanks to the support of Roche CustomBiotech.
Don't have time to watch the full video? Check out these segments by topic: